Sign in and upgrade to a paid plan to export insider/SAST/pledge disclosures as CSV.
Sign in and upgrade to a paid plan to export bulk/block deals as CSV.

Sakar Healthcare Limited

Healthcare

NSE: SAKAR
₹1093.05
▼ -28.80 (-2.57%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
—/100
Data unavailable
Valuation
—/100
Data unavailable
Momentum
51/100
Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
Data unavailable.
PE (TTM)
Data unavailable.
Price to Book
Data unavailable.
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
23.50%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
84.0
Relative return vs Sector, qtr %
Data unavailable.
Free Cash Flow
₹49 Cr
as of March 31, 2026
EPS Growth (YoY)
Data unavailable.
Net Profit Growth (TTM)
Data unavailable.
Operating Revenue Growth (TTM)
Data unavailable.
Profit Growth (YoY)
Data unavailable.
Revenue Growth (YoY)
Data unavailable.
Current Ratio
Data unavailable (needs a filed half-yearly balance sheet).
Debt to Equity
Data unavailable (needs a filed half-yearly balance sheet).
Interest Coverage
Data unavailable.
Net Margin
Data unavailable.
Operating Margin (EBIT)
Data unavailable.
Operating Margin (TTM)
Data unavailable.
Return on Assets
Data unavailable.
Return on Capital Employed
Data unavailable (needs a filed half-yearly balance sheet).
Return on Equity
Data unavailable (needs a filed half-yearly balance sheet).

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 2 met
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • No Promoter holding rose or was unchanged in the latest quarter
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Value and momentum

1 of 4 met
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-2.6%
Low 1082.0000 · High 1143.8000
1W return
-6.0%
Low 1075.0000 · High 1189.9000
1M return
26.6%
Low 864.0000 · High 1229.8500
52W return
198.0%
Low 345.5000 · High 1229.8500
Lifetime High ₹1188.4000 (Sept. 22, 2026)
Lifetime Low ₹45.9500 (June 11, 2019)

Full price history and technicals →

EMA & SMA

Bullish3
Bearish3
5D
1114.5
10D
1120.2
20D
1094.3
50D
1005.3
100D
894.1
200D
688.7

Delivery and volume

Day avg. delivery
43.5%
Week avg. delivery
47.6%
Month avg. delivery
37.1%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1106.28
Pivot
First resistance1130.57
Second resistance1168.08
Third resistance1192.37
First support1068.77
Second support1044.48
Third support1006.97
Day RSI52.9
Day MFI61.3
Day MACD43.02
Day MACD signal55.68

Beta

1M1.02
3M0.96
1Y0.73
3Y0.78

Price change analysis

↑ 26.6%
Over 1 Month
LowHigh
864.001229.85
↑ 34.6%
Over 3 Months
LowHigh
785.601229.85
↑ 112.0%
Over 6 Months
LowHigh
492.201229.85
↑ 198.0%
Over 1 Year
LowHigh
345.501229.85
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹73 Cr
Net profit (June 30, 2026)
₹10 Cr
Basic EPS (June 30, 2026)
₹

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter52.52%
  • FII/FPI12.13%
  • Public23.98%

Largest holders

NameCategoryShares %Shares
Sanjay S ShahPromoter44.9800%10008543
Tata Capital Healthcare Fund iiPublic10.3800%2309910
Hbm Healthcare Investments (Cayman) LtdPublic6.7400%1500000
Shah AarshPromoter6.3300%1407500
Cobra India (Mauritius) LimitedPublic3.9400%875780

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings decreased from 52.86% to 52.52% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 12.94% to 12.13% in Jun 2026 qtr

Historical mutual fund holding

All shareholding details →

Insider trading, SAST & pledges

All 17 insider trades, 19 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
31 Dec 2024 Aarsh S. Shah Promoter Buy 0 ₹0
31 Dec 2024 Sanjay S. Shah Promoter Buy 0 ₹0
29 Dec 2023 Sanjay S. Shah Promoter Buy 0 ₹0
29 Dec 2023 Aarsh S. Shah Promoter Buy 0 ₹0
9 Jul 2022 HBM Healthcare Investments (Cayman) Ltd Other Buy 0 ₹0
19 Apr 2021 Cobra India (Mauritius) Limited Other Buy 0 ₹0
27 Feb 2021 SANJAY S. SHAH Promoter Buy 0 ₹0
31 Dec 2019 SANJAY S. SHAH Promoter Buy 0 ₹0
30 Dec 2019 SANJAY S. SHAH Promoter Buy 0 ₹0
25 Dec 2019 SANJAY S. SHAH Promoter Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
15 May 2026 STELLAR WEALTH PARTNERS INDIA FUND I LP Bulk Buy 195,000 664.5800 NSE
17 May 2022 RATHOD SAAJAN S Bulk Buy 115,000 133.5500 NSE
17 May 2022 RATHOD SAAJAN S Bulk Sell 68,692 138.4700 NSE
17 May 2022 AFFILADO EDUCATION SYSTEM LLP Bulk Sell 113,095 130.0100 NSE
13 Jan 2022 SUBHASH RATHOD Bulk Sell 94,950 159.8800 NSE
13 Jan 2022 PADMINI VINIYOG PRIVATE LIMITED Bulk Buy 95,000 159.8800 NSE
1 Jul 2021 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 99,150 176.2100 NSE
1 Jul 2021 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 99,150 176.5900 NSE
1 Jul 2021 AFFILADO EDUCATION SYSTEM LLP Bulk Sell 100,000 175.2500 NSE
1 Apr 2021 AFFILADO EDUCATION SYSTEM LLP Bulk Sell 111,248 117.3300 NSE

All bulk and block deals →

Corporate Actions

Full history (6 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
13 Sep 2024OTHERAnnual General Meeting
14 Sep 2023OTHERAnnual General Meeting
12 Sep 2022OTHERAnnual General Meeting
16 Sep 2021OTHER Annual General Meeting
16 Sep 2020OTHER Annual General Meeting

All corporate actions →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
24 Jul 2026 Financial Results Yes
12 May 2026 Financial Results/Other business matters Yes
5 Feb 2026 Financial Results/Other business matters Yes
7 Nov 2025 Financial Results/Other business matters Yes
25 Jul 2025 Financial Results/Other business matters Yes

Corporate Announcements

All 472 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Trading Window Sakar Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
22 Sep 2026 Appointment Sakar Healthcare Limited has informed the Exchange regarding Appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditors of the Company for the term of 5 years w.e.f. September 22, 2026.
22 Sep 2026 Shareholders meeting Sakar Healthcare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2026. Further, the company has informed the Exchange regarding voting results.
22 Sep 2026 Shareholders meeting Sakar Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 22, 2026
14 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Sakar Healthcare Limited has informed the Exchange about Schedule of meet on 18th Sept., 2026
14 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Sakar Healthcare Limited has informed the Exchange about Schedule of meet on 17th Sept., 2026
1 Sep 2026 General Updates Sakar Healthcare Limited has informed the Exchange about Sakar receives 14 oncology product new approvals in the EU (Europe), UK & Canada with 7 business partners
29 Aug 2026 Copy of Newspaper Publication Sakar Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
27 Aug 2026 Shareholders meeting Sakar Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 22, 2026
3 Aug 2026 Analysts/Institutional Investor Meet/Con. Call Updates Sakar Healthcare Limited has informed the Exchange about Transcript of Con-Call.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

Data unavailable.

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Sakar Healthcare Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.